Afficher la notice abrégée

Recommendations for OCTA reporting in retinal vascular disease: A Delphi approach by International Experts

dc.rights.licenseopenen_US
dc.contributor.authorMUNK, Marion R.
dc.contributor.authorKASHANI, Amir H.
dc.contributor.authorTADAYONI, Ramin
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorKOROBELNIK, Jean-Francois
dc.contributor.authorWOLF, Sebastian
dc.contributor.authorPICHI, Francesco
dc.contributor.authorKOH, Adrian
dc.contributor.authorISHIBAZAWA, Akihiro
dc.contributor.authorGAUDRIC, Alain
dc.contributor.authorLOEWENSTEIN, Anat
dc.contributor.authorLUMBROSO, Bruno
dc.contributor.authorFERRARA, Daniela
dc.contributor.authorSARRAF, David
dc.contributor.authorWONG, David T.
dc.contributor.authorSKONDRA, Dimitra
dc.contributor.authorRODRIGUEZ, Francisco J.
dc.contributor.authorSTAURENGHI, Giovanni
dc.contributor.authorPEARCE, Ian
dc.contributor.authorKIM, Judy E.
dc.contributor.authorFREUND, K Bailey
dc.contributor.authorPARODI, Maurizio Battaglia
dc.contributor.authorWAHEED, Nadia K.
dc.contributor.authorROSEN, Richard
dc.contributor.authorSPAIDE, Richard F.
dc.contributor.authorNAKAO, Shintaro
dc.contributor.authorSADDA, SriniVas
dc.contributor.authorVUJOSEVIC, Stela
dc.contributor.authorWONG, Tien Yin
dc.contributor.authorMURATA, Toshinori
dc.contributor.authorCHAKRAVARTHY, Usha
dc.contributor.authorOGURA, Yuichiro
dc.contributor.authorHUF, Wolfgang
dc.contributor.authorTIAN, Meng
dc.date.accessioned2022-03-11T14:17:27Z
dc.date.available2022-03-11T14:17:27Z
dc.date.issued2022-02-22
dc.identifier.issn2468-6530en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/136445
dc.description.abstractEnPURPOSE: To develop a consensus nomenclature for reporting optical coherence tomography angiography (OCTA) findings in retinal vascular disease (e.g., diabetic retinopathy, retinal vein occlusion) by international experts. DESIGN: Delphi-based survey SUBJECTS, PARTICIPANTS AND/OR CONTROLS: Twenty-five retinal vascular disease and OCTA imaging experts METHODS, INTERVENTION, OR TESTING: A Delphi method of consensus development was used, comprising two rounds of online questionnaires, followed by a face-to-face meeting conducted virtually. Twenty-five experts in retinal vascular disease and retinal OCTA imaging were selected to constitute the OCTA Nomenclature in Delphi Study Group for retinal vascular disease. The four main areas of consensus were: definition of parameters of "widefield (WF)" OCTA, measurement of decreased vascular flow on conventional and WF-OCTA, nomenclature of OCTA findings, and OCTA in retinal vascular disease management and staging. The study endpoint was defined by the degree of consensus for each question: "strong consensus" was defined as ≥ 85% agreement, "consensus" as 80-84% and "near consensus" as 70-79%. MAIN OUTCOME MEASURES: Consensus and near-consensus on OCTA nomenclature in retinal vascular disease RESULTS: A consensus was reached that a meaningful change in percentage of flow on WF-OCTA imaging should be an increase or decrease ≥30% of the absolute imaged area of flow signal and that a "large area" of WF-OCTA reduced flow signal should also be defined as ≥ 30% of absolute imaged area. The presence of new vessels (NV) and intra-retinal microvascular abnormalities (IRMAs), the foveal avascular zone (FAZ) parameters, the presence and amount of "no flow" area and the assessment of vessel density in various retinal layers should be added for the staging and classification of DR. Decreased flow ≥ 30% of the absolute imaged area should define an ischemic central retinal vein occlusion (CRVO). Several other items did not meet consensus requirements or were rejected in the final discussion round. CONCLUSIONS: This study provides international consensus recommendations for reporting OCTA findings in retinal vascular disease, which may help to improve the interpretability and description in clinic and clinical trials. Further validation in these settings is warranted and ongoing. Efforts are continuing to address unresolved questions.
dc.language.isoENen_US
dc.title.enRecommendations for OCTA reporting in retinal vascular disease: A Delphi approach by International Experts
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.oret.2022.02.007en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35202889en_US
bordeaux.journalOphthalmology Retinaen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamLEHA_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressouien_US
hal.identifierhal-03606104
hal.version1
hal.date.transferred2022-03-11T14:17:30Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Ophthalmology%20Retina&rft.date=2022-02-22&rft.eissn=2468-6530&rft.issn=2468-6530&rft.au=MUNK,%20Marion%20R.&KASHANI,%20Amir%20H.&TADAYONI,%20Ramin&KOROBELNIK,%20Jean-Francois&WOLF,%20Sebastian&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée